Cetera Investment Advisers
XRAY icon

Cetera Investment Advisers’s Dentsply Sirona XRAY Stock Holding History

Cetera Investment Advisers’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$310K Buy
26,700
+5,625
+27% +$70.2K ﹤0.01% 3951
2025
Q4 		$241K Sell
21,075
-16,173
-43% -$190K ﹤0.01% 4096
2025
Q3 		$473K Buy
37,248
+10,184
+38% +$148K ﹤0.01% 3425
2025
Q2 		$430K Buy
27,064
+5,839
+28% +$87.3K ﹤0.01% 3083
2025
Q1 		$317K Sell
21,225
-8,801
-29% -$156K ﹤0.01% 3221
2024
Q4 		$570K Sell
30,026
-3,454
-10% -$73K ﹤0.01% 2577
2024
Q3 		$906K Buy
33,480
+967
+3% +$24.7K ﹤0.01% 2191
2024
Q2 		$810K Buy
32,513
+3,235
+11% +$92.8K ﹤0.01% 2236
2024
Q1 		$972K Buy
+29,278
New +$1M ﹤0.01% 2089
2021
Q4 		– Sell
-6,305
Closed -$366K – 1934
2021
Q3 		$366K Buy
6,305
+300
+5% +$18.5K 0.01% 1316
2021
Q2 		$380K Buy
+6,005
New +$396K 0.01% 1274
2021
Q1 		– Sell
-6,296
Closed -$330K – 1718
2020
Q4 		$330K Buy
+6,296
New +$311K 0.01% 1190

Other funds holding XRAY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Cetera Investment Advisers's XRAY Position: Q1 2026 in Review

Cetera Investment Advisers increased its Dentsply Sirona (XRAY) stake by 27% in Q1 2026, buying an estimated $70.2K and bringing the position to 26,700 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #3951.

Cetera Investment Advisers first reported a position in XRAY in Q4 2020 and has held it in 12 quarters since. The position peaked at $972K in Q1 2024. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Cetera Investment Advisers held 26,700 shares of Dentsply Sirona worth $310K as of Q1 2026.
  • Cetera Investment Advisers bought 5,625 Dentsply Sirona shares in Q1 2026, an estimated $70.2K.
  • Dentsply Sirona made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #3951 holding.
  • Cetera Investment Advisers first reported a position in Dentsply Sirona in Q4 2020 and has held it in 12 quarters since.
  • Cetera Investment Advisers's Dentsply Sirona position peaked at $972K in Q1 2024.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.